SCHEMBL31105546

SCHEMBL31105546

CC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(N)=O)C(C)C

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CAPN1 P07384 2/20 0.58
▸ CTSB P07858 2/20 0.58
▸ NTSR2 O95665 1/20 0.57
▸ NTSR1 P30989 1/20 0.57
▸ SORT1 Q99523 1/20 0.57
▸ C5AR1 P21730 2/20 0.56
▸ NMBR P28336 2/20 0.56
▸ GRPR P30550 2/20 0.56
▸ KISS1R Q969F8 5/20 0.54
▸ CTSL P07711 3/20 0.52
▸ CTSS P25774 3/20 0.52
▸ CTSK P43235 3/20 0.52
▸ CTSH P09668 1/20 0.52
▸ CXCR4 P61073 1/20 0.51
▸ MC4R P32245 2/20 0.50
▸ MC5R P33032 2/20 0.50
▸ MC3R P41968 2/20 0.50
▸ MC1R Q01726 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30518116 0.95 NTSR2 (0.58) CAPN1CTSBNTSR2NTSR1SORT1
SCHEMBL31105542 0.93 NTSR2 (0.64) CAPN1CTSBNTSR2NTSR1SORT1
SCHEMBL31105525 0.91 C5AR1 (0.58) CAPN1CTSBNTSR2NTSR1SORT1
SCHEMBL30518080 0.89 NTSR2 (0.65) CAPN1CTSBNTSR2NTSR1SORT1
SCHEMBL30608996 0.89 CAPN1 (0.58) CAPN1CTSBNTSR2NTSR1SORT1
SCHEMBL31238544 0.86 KISS1R (0.57) CAPN1CTSBC5AR1NMBRGRPR
SCHEMBL30605453 0.84 NMBR (0.59) NTSR2NTSR1SORT1C5AR1NMBR
SCHEMBL30123592 0.84 GRPR (0.57) NTSR2NTSR1SORT1C5AR1NMBR
SCHEMBL30608422 0.84 CTSL (0.55) CAPN1CTSBNTSR2NTSR1SORT1
SCHEMBL31238594 0.84 KISS1R (0.62) CAPN1CTSBC5AR1NMBRGRPR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078144-A1 ACTIVE PEPTIDE, AND COMPOSITION AND USE THEREOF WINKEY TECH USA INC (US) 2026-03-19 — — US claimed
WO-2024217503-A1 ACTIVE PEPTIDE, AND COMPOSITION AND USE THEREOF 深圳市维琪科技股份有限公司 2024-10-24 — — WO claimed
US-20260078144-A1 ACTIVE PEPTIDE, AND COMPOSITION AND USE THEREOF WINKEY TECH USA INC (US) 2026-03-19 — — US disclosed
WO-2024217503-A1 ACTIVE PEPTIDE, AND COMPOSITION AND USE THEREOF 深圳市维琪科技股份有限公司 2024-10-24 — — WO disclosed
CN-117343140-B Active peptide, composition and use thereof 深圳市维琪科技股份有限公司 2024-09-20 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078144-A1 ACTIVE PEPTIDE, AND COMPOSITION AND USE THEREOF ARGLU1, ARG1, POT1 CAPN1 2140/4885CTSB 2401/4885NTSR2 2409/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback